Pre | Post | Follow-up (FU) | Χ 2(df) | p | ES pre-post† | ES pre-FU† | |
---|---|---|---|---|---|---|---|
WSAS | |||||||
All patients | 20.59 (0.56)a | 15.76 (0.56)b | 76.51 (1) | < .001 | — | 0.61 | |
Type 2 diabetes | 12.39 (1.30)a | 10.51 (1.12)a | 2.50 (1) | .11 | — | 0.27 | |
Chronic low back pain | 21.53(0.78)a | 17.48 (0.85)b | 26.92 (1) | < .001 | — | 0.45 | |
Long COVID | 24.38 (1.00)a | 16.72 (0.98)b | 70.13 (1) | < .001 | — | 1.04 | |
BIPQ1 | |||||||
All patients | 22.30 (0.43)a | 16.32 (0.42)b | 14.88 (0.47)c | 256.57 (2) | < .001 | 1.02 | 1.35 |
Type 2 diabetes | 18.51 (0.83)a | 12.57 (0.77)b | 12.34 (0.80)b | 61.39 (2) | < .001 | 0.98 | 1.00 |
Chronic low back pain | 23.44 (0.67)a | 19.06 (0.66)b | 17.63 (1.06)b | 49.66 (2) | < .001 | 0.79 | 1.02 |
Long COVID | 24.55 (0.72)a | 16.72 (0.73)b | 14.86 (0.70)c | 175.64 (2) | < .001 | 1.52 | 1.89 |
BIPQ2 | |||||||
All patients | 20.79 (0.38)a | 18.18 (0.37)b | 17.70 (0.42)b | 63.63 (2) | < .001 | 0.51 | 0.85 |
Type 2 diabetes | 19.19 (0.73)a | 17.31 (0.68)b | 17.60 (0.71)b | 7.20 (2) | < .05 | 0.35 | 0.31 |
Chronic low back pain | 23.21 (0.59)a | 21.74 (0.58)b | 20.67 (0.92)b | 10.01 (2) | < .01 | 0.29 | .59 |
Long COVID | 19.94 (0.64)a | 15.48 (0.64)b | 15.07 (0.63)b | 66.79 (2) | < .001 | 1.10 | 1.24 |